Compare, Analyse ASTRAZENECA PHARMA with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ASTRAZENECA PHARMA     Change

AstraZeneca Pharma India Limited (APIL) is a 90% subsidiary of the UK based AstraZeneca Pharmaceuticals, which is one of the world's leading pharma companies. APIL has interests in the six crucial areas of cardiovascular, respiratory, maternal health... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ASTRAZENECA PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-18
ADCOCK INGRAM
Jun-14
ASTRAZENECA PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs1,278305-   
Low Rs883220-   
Sales per share (Unadj.) Rs228.490.6-  
Earnings per share (Unadj.) Rs10.4-22.8-  
Cash flow per share (Unadj.) Rs16.3-18.9-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs98.871.1-  
Shares outstanding (eoy) m25.00168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.72.9 163.5%   
Avg P/E ratio x104.2-11.5 -907.8%  
P/CF ratio (eoy) x66.4-13.9 -479.5%  
Price / Book Value ratio x10.93.7 296.7%  
Dividend payout %00-   
Avg Mkt Cap Rs m27,00844,234 61.1%   
No. of employees `0001.44.3 31.6%   
Total wages/salary Rs m1,5352,776 55.3%   
Avg. sales/employee Rs Th4,210.93,561.1 118.2%   
Avg. wages/employee Rs Th1,132.2646.7 175.1%   
Avg. net profit/employee Rs Th191.1-897.3 -21.3%   
INCOME DATA
Net Sales Rs m5,71015,288 37.3%  
Other income Rs m123107 114.4%   
Total revenues Rs m5,83315,395 37.9%   
Gross profit Rs m463-2,649 -17.5%  
Depreciation Rs m147660 22.3%   
Interest Rs m0414 0.0%   
Profit before tax Rs m438-3,616 -12.1%   
Minority Interest Rs m0-10 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m179226 79.2%   
Profit after tax Rs m259-3,852 -6.7%  
Gross profit margin %8.1-17.3 -46.8%  
Effective tax rate %40.8-6.2 -653.7%   
Net profit margin %4.5-25.2 -18.0%  
BALANCE SHEET DATA
Current assets Rs m3,20911,197 28.7%   
Current liabilities Rs m2,0706,300 32.8%   
Net working cap to sales %20.032.0 62.3%  
Current ratio x1.61.8 87.2%  
Inventory Days Days72111 65.2%  
Debtors Days Days35124 28.2%  
Net fixed assets Rs m7906,527 12.1%   
Share capital Rs m5071 70.4%   
"Free" reserves Rs m2,4190-   
Net worth Rs m2,46911,999 20.6%   
Long term debt Rs m04,217 0.0%   
Total assets Rs m4,60522,668 20.3%  
Interest coverage xNM-7.7-  
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x1.20.7 183.8%   
Return on assets %5.6-15.2 -37.1%  
Return on equity %10.5-32.1 -32.7%  
Return on capital %17.7-19.8 -89.5%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-1,7150-   
CASH FLOW
From Operations Rs m881,305 6.7%  
From Investments Rs m-94-401 23.4%  
From Financial Activity Rs mNA3,827 0.0%  
Net Cashflow Rs m-64,731 -0.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.2 Rs / ZAR

Compare ASTRAZENECA PHARMA With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare ASTRAZENECA PHARMA With: CIPLA  DR. DATSONS LABS  SUVEN LIFESCIENCES  AUROBINDO PHARMA  FDC LTD.  



Today's Market

Indian Indices End Lower, LIC IPO, Stocks in Focus, and Top Cues to Track Today(Pre-Open)

Indian share markets ended on a negative note yesterday, tracking weakness in global markets owing to coronavirus outbreak.

Related Views On News

ASTRAZENECA PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 236.5% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ASTRAZENECA PHARMA has posted a net profit of Rs 215 m (up 236.5% YoY). Sales on the other hand came in at Rs 2 bn (up 26.7% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 204.9% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, ASTRAZENECA PHARMA has posted a net profit of Rs 98 m (up 204.9% YoY). Sales on the other hand came in at Rs 2 bn (up 26.3% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Mar 29, 2019 | Updated on Mar 29, 2019

Here's an analysis of the annual report of ASTRAZENECA PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of ASTRAZENECA PHARMA. Also includes updates on the valuation of ASTRAZENECA PHARMA.

More Views on News

Most Popular

Sorry Warren Buffett, I'm Following This Man Instead of You in 2020 (The 5 Minute Wrapup)

Mar 30, 2020

This man warned of an impending market correction while everyone else was celebrating the renewed optimism in early 2020...

One Stock that is All Charged Up for the Post Coronavirus Rebound (The 5 Minute Wrapup)

Apr 1, 2020

A stock with strong moat is currently trading near 5-year lows.

A Safe Stock to Lockdown Now (The 5 Minute Wrapup)

Apr 2, 2020

The market crashc has made strong, established brands attractive. Here's a stock to make the most of this opportunity...

The Insiders See a Buying Opportunity in These Smallcaps Amid Coronavirus Outbreak (Profit Hunter)

Mar 31, 2020

The promoters are buying these smallcaps amid the coronavirus outbreak.

How to Identify a Market Rebound (Fast Profits Daily)

Mar 27, 2020

This very useful indicator can spot a market bottom.

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

How to Trade the Coronavirus Crash - Download this FREE Report Now
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
Free Report: The Secret to Increasing Your Trading Profits Daily!
Find Out Our Top 7 Bluechips for 2020 Virtually FREE. Click Here Now!

ASTRAZENECA PHARMA SHARE PRICE


Apr 8, 2020 (Close)

TRACK ASTRAZENECA PHARMA

  • Track your investment in ASTRAZENECA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ASTRAZENECA PHARMA

ASTRAZENECA PHARMA - VENUS REMEDIES COMPARISON

COMPARE ASTRAZENECA PHARMA WITH

OTHER USEFUL LINKS

MARKET STATS